Skip to content
Developing the Moderna COVID-19 Vaccine episode artwork

Mar 8, 2021 54 min

Developing the Moderna COVID-19 Vaccine

from Lung Cancer Considered Hosted by IASLC

This special episode of Lung Cancer Considered features a conversation between host Dr. Stephen Liu and co-host Paul Bunn. Dr. Liu and Dr. Bunn are joined by, Dr. Tal Zaks, the chief medical officer at Moderna, and Dr. Amy Moore, a trained virologist and cancer researcher. Dr. Bunn is the founding director of the University of Colorado Cancer Center, former president of IASLC and ASCO. Dr. Moore serves as the director of Science and Research for the GO2 Foundation for Lung Cancer. Together, they discuss the development of the Moderna COVID-19 vaccine what lung cancer patients, doctors and advocates should know.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Developing the Moderna COVID-19 Vaccine

0:00 54:34

No transcript yet.

Requests help us decide what to transcribe next.

Share this episode

Similar podcasts

Lung Cancer Update for Nurses Dr Neil Love Featuring one-on-one interviews conducted by Dr Neil Love with national lung cancer clinical investigators and oncology nurses, this series provides practicing clinicians including nurses and nurse practitioners with valuable information and current clinical management strategies that can be applied to optimize patient care.

Frequently asked questions

How long is this episode of Lung Cancer Considered?

This episode is 54 minutes long.

When was this Lung Cancer Considered episode published?

This episode was published on March 8, 2021.

Can I download this Lung Cancer Considered episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.